Medical News
Addiction
Allergies
Alternative Medicine
Asthma
Cancer
Cardiology
Chiropractic
Dental
Dermatology
Diabetes
Emergency
Family Medicine
General
Geriatrics
Hospitals
Infectious Diseases
Internal Medicine
Managed Care / HMO
Medical Products
Mental Health
Neurology
Nursing
Nutrition
OB / GYN
Pediatrics
Pharmaceuticals
Physical Therapy
Plastic Surgery
Psychology
Radiology / Imaging
Research
Sports Medicine
Surgery
Vision

Transforming Drug Discovery Through Genomics and Proteomics - New Report

"Transforming Drug Discovery through Genomics and Proteomics," a new report published by Pharma-Reports.com, looks at how advances in genomics and proteomics are transforming the landscape of drug discovery and drug development (http://pharma-reports.com/shop/item.asp?itemid=8&affillink=EPRW20080130).

(PRWEB) January 30, 2008 -- "Transforming Drug Discovery through Genomics and Proteomics," a new report published by Pharma-Reports.com, looks at how advances in genomics and proteomics are transforming the landscape of drug discovery and drug development.

Genomics is a science that studies the structure and function of genomes and, in particular, genes. A genome is an organism's complete genetic signature. It is the palate of information an organism can call on in order to ensure its own survival and growth. Meanwhile, proteomics is essentially protein analysis. It is typically associated with systems biology. Powerful new technologies for differential complexity reduction are expected to solve some of the most pressing problems in drug development.

The report analyzes the basics and processes of both genomics and proteomics, the various technologies involved in the process of drug development, genomics and proteomics. The report aids in the understanding of drug development with the help of genomics and proteomics.

Other Topics covered in this report include:
Genomics and Implications of the Human Genome Project
Proteomics Processes
Regulatory Approval of Pharmaceuticals
Future Outlook for the Drug Discovery Market

More details on this report can be found at
http://pharma-reports.com/shop/item.asp?itemid=8&affillink=EPRW20080130

About the Publisher: "Transforming Drug Discovery Through Genomics and Proteomics " is published by Pharma-Reports (www.Pharma-Reports.com), a pharmaceutical and biotechnology industry think tank and leading source for pharmaceutical and biotechnology industry information and research products. Details on all reports can be found at http://pharma-reports.com

# # #

Simillar Articles

Global Drug Discovery Technologies Market to Exceed $57 Billion by 2012, According to a New...
Driven by the emergence of innovative technologies such as microfluidics, genomics, high throughput screening and proteomics, world market for drug discovery technologies is projected to reach...
Biotech Support Group LLC and ProFACT Proteomics Inc., Form a Strategic Alliance to Provide...
Biotech Support Group LLC and ProFACT Proteomics Inc., form a strategic alliance to provide consulting services in the field of profiling serum protein for proteomic analysis by using...
Celebrate DNA Day with Free NCBI Map Viewer Tutorial
Get free access to the OpenHelix web-based narrated tutorial on NCBI Map Viewer genome browser.
Stem Cell Research in the Spotlight Once Again
Ethical and moral issues over embryonic stem cell research
Chenomx, Inc. Partners with Assay Depot to Offer Routine Metabolite Analysis Services for Drug...
Chenomx, Inc. (www.chenomx.com) is pleased to announce a partnership with Assay Depot (www.assaydepot.com) to offer routine metabolite analysis services for drug discovery. Chenomx offers a cost...
Home Terms of Use Privacy Policy Contact Us